As of December 31, 2024, Abliva AB (publ) has 1.61B shares outstanding.
| Shares Outstanding | 1.61B |
These figures are as of December 31, 2024.
| PB Ratio | -0.63 |
| P/TBV Ratio | 11.14 |
| P/FCF Ratio | -5.54 |
| P/OCF Ratio | -5.48 |
As of December 31, 2024, Abliva AB (publ) maintains a current ratio of 4.13, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.13 |
| Quick Ratio | 2.75 |
| Interest Coverage | -1,861.59 |
These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -111.71, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -111.71 |
As of the close on March 17, 2025, Abliva AB (publ)'s stock has gained approximately 196.79% over the past 52 weeks. The 50-day moving average sits at 0.44, while the 200-day moving average is 0.25.
| 52-Week Price Change | 196.79% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.25 |
These figures cover the twelve months ended December 31, 2024. Free cash flow yield is negative at -18.05: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -14.02, meaning Abliva AB (publ) raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -14.02 |
| FCF Yield | -18.05 |
Abliva AB (publ)'s most recent stock split took place on June 7, 2022 with a 125:128 split ratio.
| Last Split Date | 6/7/2022 |
| Split Ratio | 125:128 |
As of December 31, 2024, Abliva AB (publ) has an Altman Z-Score of 2.46, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.46 |
Already premium?